CoChat

The gut microbiome and response to immune checkpoint inhibitors: preclinical and clinical strategies

Open access
Gong, Jun, Chehrazi‐Raffle, Alexander, Placencio‐Hickok, Veronica, Guan, Michelle, Hendifar, Andrew, Salgia, Ravi · 2019 · Clinical and Translational Medicine
Cited by 113

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Abstract

There is growing interest in identifying predictive biomarkers for inhibitors of programmed cell death protein 1 receptor (PD‐1), programmed death ligand 1 (PD‐L1), and cytotoxic T‐lymphocyte associated protein 4 (CTLA‐4). Given the links between the stool microbiota, anticancer immunosurveillance, and general health, the composition of the gut microbiome has recently undergone investigation as a biomarker for immunotherapy. In this review, we highlight published results from preclinical and clinical studies to date supporting a relationship between the gut microbiome and antitumor efficacy of immune checkpoint inhibitors. Despite the promising and hypothesis‐generating findings that have been produced in this arena to date, there remain some inconsistencies amongst present data that may need to be resolved to contribute to further development. Among these, a better understanding of the immunomodulatory function of the microbiome, standardization in sampling, sequencing techniques, and data analysis, and ensuring uniformity across various aspects of study design are warranted in conducting future prospective studies seeking to validate the gut microbiome as a potential biomarker of response to checkpoint blockade.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s40169-019-0225-x

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Cited by

See all 113

Metadata

Authors
Gong, J., Chehrazi‐Raffle, A., Placencio‐Hickok, V., Guan, M., Hendifar, A., & Salgia, R.
Venue
Clinical and Translational Medicine
Publisher
Wiley
Published
2019-03-18
Volume
8
Issue
1
Pages
9-9
ISSN
2001-1326 (ISSN-L)
OpenAlex
W2938994710
Cited by
113
References
20
FWCI
6.35
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The gut microbiome and response to immune checkpoint inhibitors: preclinical and clinical strategies. https://app.cochat.ai/papers/10.1186/s40169-019-0225-x
The paper
Gong, J., Chehrazi‐Raffle, A., Placencio‐Hickok, V., Guan, M., Hendifar, A., & Salgia, R. (2019). The gut microbiome and response to immune checkpoint inhibitors: preclinical and clinical strategies. Clinical and Translational Medicine. https://doi.org/10.1186/s40169-019-0225-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.